Patents by Inventor Allan Rozenberg

Allan Rozenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11364032
    Abstract: Provided herein is a clamp device that can be used in minimally invasive procedures, including surgeries such as laparoscopic surgeries, for clamping a tissue or an organ or a portion of a tissue or organ. Also provided herein are methods of clamping a tissue or an organ or a portion thereof during minimally invasive surgery using the clamp device provided herein. Also provided are systems for performing a minimally invasive surgery that include the clamp device for minimally invasive surgery provided herein and an injection device configured to access an endoscopic port for the minimally invasive surgery.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: June 21, 2022
    Assignee: Global Bio Therapeutics, Inc.
    Inventors: Jose Gustavo Cabrera Aquino, Blanca Angelica Segura Pacheco, Steven Masterson, Allan Rozenberg, Paul Faucher, John Hoffman
  • Patent number: 10561527
    Abstract: Devices for cerebral and systemic cooling via a patient's nasopharyngeal cavity are described. Cooling assemblies include at least one elongate tubular member having first and second lumens, a source of liquid coolant, a gas source communicating with the first lumen, and a switch for alternately connecting the liquid coolant source to the second lumen. The first lumen transports a compressed gas and the second lumen transports a volatile liquid. The pressurized fluid may be a perfluorocarbon. The perfluorocarbon may be perfluorohexane, perfluoropentane, or 2-methyl-perfluoropentane. The gas may be air, oxygen, or a combination.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: February 18, 2020
    Assignee: BrainCool AB
    Inventors: Allan Rozenberg, Denise Barbut, John K Hoffman, Thomas H Shaffer
  • Patent number: 10076441
    Abstract: A method for cerebral cooling is described using a cooling assembly, which includes first and second elongate tubular members adapted for insertion into a nasal cavity of a patient through the patient's nostrils. The elongate tubular members each have a proximal end, a distal end, a lumen extending therebetween, and a plurality of ports in fluid communication with the lumen. The cooling assembly also includes a manifold and a reservoir, which contains a pressurized fluid that includes a propellant having a boiling point less than 22° C. The elongate tubular members are inserted into the nasal cavity through the patient's nostrils and pressurized fluid is delivered onto a surface of the nasal cavity by infusing the pressurized fluid from the reservoir through the manifold, into the lumens and through the plurality of ports of the first and second elongate tubular members.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: September 18, 2018
    Assignee: BrainCool AB
    Inventors: Allan Rozenberg, John K Hoffman, James D Savage
  • Publication number: 20170027745
    Abstract: Devices for cerebral and systemic cooling via a patient's nasopharyngeal cavity are described. Cooling assemblies include at least one elongate tubular member having first and second lumens, a source of liquid coolant, a gas source communicating with the first lumen, and a switch for alternately connecting the liquid coolant source to the second lumen. The first lumen transports a compressed gas and the second lumen transports a volatile liquid. The pressurized fluid may be a perflurocarbon. The perfluorocarbon may be perfluorohexane, perfluoropentane, or 2-methyl-perfluoropentane. The gas may be air, oxygen, or a combination.
    Type: Application
    Filed: June 2, 2016
    Publication date: February 2, 2017
    Inventors: Allan ROZENBERG, Denise BARBUT, John K. HOFFMAN, Thomas H. SHAFFER
  • Publication number: 20170027746
    Abstract: A method for cerebral cooling is described using a cooling assembly, which includes first and second elongate tubular members adapted for insertion into a nasal cavity of a patient through the patient's nostrils. The elongate tubular members each have a proximal end, a distal end, a lumen extending therebetween, and a plurality of ports in fluid communication with the lumen. The cooling assembly also includes a manifold and a reservoir, which contains a pressurized fluid that includes a propellant having a boiling point less than 22° C. The elongate tubular members are inserted into the nasal cavity through the patient's nostrils and pressurized fluid is delivered onto a surface of the nasal cavity by infusing the pressurized fluid from the reservoir through the manifold, into the lumens and through the plurality of ports of the first and second elongate tubular members.
    Type: Application
    Filed: June 6, 2016
    Publication date: February 2, 2017
    Applicant: BrainCool AB
    Inventors: ALLAN ROZENBERG, JOHN K HOFFMAN, JAMES D SAVAGE
  • Patent number: 9358150
    Abstract: Methods for cerebral and systemic cooling via a patient's nasopharyngeal cavity are described. In one method, a cooling assembly is inserted into a nasal cavity through a patient's nostril. A substantially dry gas is delivered through a lumen of the catheter onto the surface of the patient's nasal cavity. Evaporative heat loss cools the patient's nasal cavity. If additional cooling is needed, a liquid coolant is delivered through a separated lumen of the catheter. The liquid coolant is nebulized at a plurality of delivery ports on the distal end of the catheter and is delivered onto the surface of the patient's nasal cavity in combination with the dry gas. The dry gas enhances evaporation of the nebulized coolant and additional cooling is provided from the evaporative heat loss of the liquid coolant.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: June 7, 2016
    Assignee: BeneChill, Inc.
    Inventors: Allan Rozenberg, Denise Barbut, John K Hoffman, Thomas H Shaffer
  • Patent number: 9265922
    Abstract: A system for improving outcome following cerebral ischemia is provided. The system includes a source of nitric oxide and an elongate tubular member for insertion into a nose including at least one orifice thereon. The elongate tubular member is coupled to the source of nitric oxide and configured for delivering the nitric oxide into a nasal cavity through the at least one orifice for absorption into a cerebral vasculature through a nasal vasculature. A device for controlling flow of the gas, a concentration of the nitric oxide in the gas, or both, is also provided.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: February 23, 2016
    Assignee: ASTUCE, INC.
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20150066056
    Abstract: Provided herein is a clamp device that can be used in minimally invasive procedures, including surgeries such as laparoscopic surgeries, for clamping a tissue or an organ or a portion of a tissue or organ. Also provided herein are methods of clamping a tissue or an organ or a portion thereof during minimally invasive surgery using the clamp device provided herein. Also provided are systems for performing a minimally invasive surgery that include the clamp device for minimally invasive surgery provided herein and an injection device configured to access an endoscopic port for the minimally invasive surgery.
    Type: Application
    Filed: August 8, 2014
    Publication date: March 5, 2015
    Inventors: Jose Gustavo Cabrera Aquino, Blanca Angelica Segura Pacheco, Steven Masterson, Allan Rozenberg, Paul Faucher, John Hoffman
  • Patent number: 8721699
    Abstract: A method for providing and adjusting cerebral cooling in response to changes in a physiological parameter. A spray having a boiling point between 38-300° C. is delivered to the surface of a patient's nasal cavities. The spray causes cooling by direct heat transfer through the nasopharynx and hematogenous cooling through the carotids and the Circle of Willis. A physiological parameter, such as cerebral temperature, changes in cerebral blood flow or brain oxygenation is monitored. The delivery rate of the spray is adjusted in response to the physiological parameter.
    Type: Grant
    Filed: February 10, 2010
    Date of Patent: May 13, 2014
    Assignee: BeneChill, Inc.
    Inventors: Denise Barbut, Allan Rozenberg, John K Hoffman
  • Publication number: 20140088562
    Abstract: A method of modulating a physiological parameter of a patient is provided. The method includes disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion and improving the physiological parameter. The method further includes destroying a pre-aortic ganglion cell to prevent regeneration.
    Type: Application
    Filed: November 4, 2013
    Publication date: March 27, 2014
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130331813
    Abstract: A method of modulating a physiological parameter of a patient by percutaneously or transcutaneously disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion via the anterior abdominal wall and improving the physiological parameter is provided. The pre-aortic ganglion cells may be disabled by applying radiofrequency, high intensity or low intensity focused ultrasound.
    Type: Application
    Filed: March 14, 2013
    Publication date: December 12, 2013
    Applicant: ENIGMA MEDICAL, INC.
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130331915
    Abstract: A method for cerebral cooling is described using a cooling assembly, which includes first and second elongate tubular members adapted for insertion into a nasal cavity of a patient through the patient's nostrils. The elongate tubular members each have a proximal end, a distal end, a lumen extending therebetween, and a plurality of ports in fluid communication with the lumen. The cooling assembly also includes a manifold and a reservoir, which contains a pressurized fluid that includes a propellant having a boiling point less than 22° C. The elongate tubular members are inserted into the nasal cavity through the patient's nostrils and pressurized fluid is delivered onto a surface of the nasal cavity by infusing the pressurized fluid from the reservoir through the manifold, into the lumens and through the plurality of ports of the first and second elongate tubular members.
    Type: Application
    Filed: August 9, 2013
    Publication date: December 12, 2013
    Applicant: BeneChill, Inc.
    Inventors: ALLAN ROZENBERG, JOHN K. HOFFMAN, JAMES D. SAVAGE
  • Publication number: 20130302445
    Abstract: A non-invasive method of treating cerebral ischemia, involving the use of non-inhaled, intra-nasally delivered carbon dioxide (CO2), alone or in combination with other gases to augment cerebral perfusion and improve outcome following a stroke is provided. A vasodilator gas is delivered intranasally, alone or in combination with a second gas, for prolonged periods of time without systemic absorption. The second gas may be selected from NO, hydrogen, xenon, anesthetic gases, oxygen, nitrogen, nitrous oxide, carbon monoxide, or air. The treatment selectively increases cerebral perfusion and provides neuroprotection in the treatment of cerebral ischemia.
    Type: Application
    Filed: April 16, 2013
    Publication date: November 14, 2013
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130296443
    Abstract: A method of modulating a physiological parameter of a patient is provided. The method includes disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion trans-venously and improving the physiological parameter. The method further includes destroying a pre-aortic ganglion cell trans-venously to prevent regeneration.
    Type: Application
    Filed: March 6, 2013
    Publication date: November 7, 2013
    Applicant: ENIGMA MEDICAL, INC.
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130296646
    Abstract: A method of ablating the sympathetic ganglionic cell bodies in the thoracic paravertebral space is provided. The method includes ablating the sympathetic ganglionic cell bodies in the thoracic paravertebral space through a posterior, non-invasive or minimally invasive approach for the treatment of resistant hypertension. The ablation may additionally involve various permutations of the gray and white rami and the dorsal root ganglion in addition to the sympathetic chain ganglionic cell bodies, all located in the triangular paravertebral space.
    Type: Application
    Filed: March 6, 2013
    Publication date: November 7, 2013
    Applicant: Enigma Medical, Inc.
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinimann
  • Publication number: 20130296836
    Abstract: A method of modulating a physiological parameter of a patient is provided. The method includes disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion and improving the physiological parameter. The method further includes destroying a pre-aortic ganglion cell to prevent regeneration.
    Type: Application
    Filed: March 6, 2013
    Publication date: November 7, 2013
    Applicant: ENIGMA MEDICAL, INC.
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130274651
    Abstract: A system for improving outcome following cerebral ischemia is provided. The system includes a source of nitric oxide and an elongate tubular member for insertion into a nose including at least one orifice thereon. The tubular member is coupled to the source of nitric oxide and the elongate tubular member configured for delivering the nitric oxide into a nasal cavity through the at least one orifice for absorption into a cerebral vasculature through a nasal vasculature. A means for controlling flow of the gas, a concentration of the nitric oxide in the gas, or both, is also provided.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 17, 2013
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130273180
    Abstract: A method for improving outcome following cerebral ischemia is provided. The method includes delivering nitric oxide into the nasal cavity for absorption into the brain through the nasal vasculature and maintaining the nitric oxide in the nasal cavity.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 17, 2013
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130273179
    Abstract: A method for improving outcome following cerebral ischemia is provided. The method includes delivering nitric oxide into the nasal cavity for absorption into the brain through the nasal vasculature and preventing the inhalation of nitric oxide into the lungs to prevent pulmonary vasodilatation.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 17, 2013
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann
  • Publication number: 20130269692
    Abstract: A system for improving outcome following cerebral ischemia is provided. The system includes a source of nitric oxide and an elongate tubular member for insertion into a nose including at least one orifice thereon. The tubular member is coupled to the source of nitric oxide and the elongate tubular member configured for delivering the nitric oxide into a nasal cavity through the at least one orifice for absorption into a cerebral vasculature through a nasal vasculature. A means for controlling flow of the gas, a concentration of the nitric oxide in the gas, or both, is also provided.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 17, 2013
    Inventors: Denise Barbut, Allan Rozenberg, Axel Heinemann